Compare Stocks

Date Range: 

 Angion BiomedicaTheratechnologiesPfenexTerns PharmaceuticalsSensei Biotherapeutics
SymbolNASDAQ:ANGNTSE:THNYSEAMERICAN:PFNXNASDAQ:TERNNASDAQ:SNSE
Price Information
Current Price$13.82C$4.25$12.75$17.05$12.08
52 Week RangeBuyHoldHoldBuyBuy
MarketRank™
Overall Score1.60.70.72.02.0
Analysis Score3.51.01.23.53.5
Community Score4.52.42.45.05.0
Dividend Score0.00.00.00.00.0
Ownership Score0.00.00.01.71.7
Earnings & Valuation Score0.00.00.00.00.0
Analyst Ratings
Consensus RecommendationBuyHoldHoldBuyBuy
Consensus Price Target$59.33C$3.75$13.67$30.50$29.50
% Upside from Price Target329.33% upside-11.76% downside7.19% upside78.89% upside144.21% upside
Trade Information
Market Cap$407.47 millionC$402.05 million$437.29 million$428.38 million$369.50 million
BetaN/AN/AN/AN/AN/A
Average Volume155,366197,523503,865173,324189,841
Sales & Book Value
Annual RevenueN/AC$65.76 millionN/AN/AN/A
Price / SalesN/A6.11N/AN/AN/A
CashflowN/AC$0.59 per shareN/AN/AN/A
Price / CashN/A7.22N/AN/AN/A
Book ValueN/AC$0.43 per shareN/AN/AN/A
Price / BookN/A9.86N/AN/AN/A
Profitability
Net IncomeN/AN/AN/AN/AN/A
EPSN/AC($0.38)N/AN/AN/A
Trailing P/E Ratio0.00N/A0.000.000.00
Forward P/E Ratio
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/AN/AN/AN/A
Return on Equity (ROE)N/AN/AN/AN/AN/A
Return on Assets (ROA)N/AN/AN/AN/AN/A
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A138.02%N/AN/AN/A
Current RatioN/A2.59%N/AN/AN/A
Quick RatioN/A1.73%N/AN/AN/A
Ownership Information
Institutional Ownership PercentageN/AN/AN/AN/AN/A
Insider Ownership PercentageN/AN/AN/AN/AN/A
Miscellaneous
EmployeesN/A5471N/AN/A
Shares Outstanding29.48 million94.60 million34.30 million25.13 million30.59 million
Next Earnings Date6/29/2021 (Estimated)7/21/2021 (Estimated)N/A6/29/2021 (Estimated)6/24/2021 (Estimated)
OptionableNot OptionableNot OptionableOptionableNot OptionableNot Optionable
SourceHeadline
Sensei Biotherapeutics Appoints Maura Gillison, M.D., Ph.D., and Richard Ulevitch, Ph.D., to its Immuno-Oncology Advisory BoardSensei Biotherapeutics Appoints Maura Gillison, M.D., Ph.D., and Richard Ulevitch, Ph.D., to its Immuno-Oncology Advisory Board
finance.yahoo.com - May 5 at 12:28 PM
What Percentage Of Sensei Biotherapeutics, Inc. (NASDAQ:SNSE) Shares Do Insiders Own?What Percentage Of Sensei Biotherapeutics, Inc. (NASDAQ:SNSE) Shares Do Insiders Own?
finance.yahoo.com - May 4 at 1:16 PM
Sensei Biotherapeutics Inc.Sensei Biotherapeutics Inc.
barrons.com - April 23 at 2:26 AM
Sensei Biotherapeutics, Inc. (NASDAQ:SNSE) Director James Peyer Acquires 1,965 SharesSensei Biotherapeutics, Inc. (NASDAQ:SNSE) Director James Peyer Acquires 1,965 Shares
americanbankingnews.com - April 20 at 4:36 PM
Sensei Biotherapeutics Inc (SNSE)Sensei Biotherapeutics Inc (SNSE)
in.investing.com - April 20 at 9:55 AM
Cambrian Biopharma Inc Buys 2,000 Shares of Sensei Biotherapeutics, Inc. (NASDAQ:SNSE) StockCambrian Biopharma Inc Buys 2,000 Shares of Sensei Biotherapeutics, Inc. (NASDAQ:SNSE) Stock
americanbankingnews.com - April 14 at 7:54 PM
Sensei Biotherapeutics Appoints Jessie M. English, Ph.D. to its Board of DirectorsSensei Biotherapeutics Appoints Jessie M. English, Ph.D. to its Board of Directors
finance.yahoo.com - April 5 at 12:58 PM
Sensei Biotherapeutics Reports Full Year 2020 Results and Provides Business UpdateSensei Biotherapeutics Reports Full Year 2020 Results and Provides Business Update
finance.yahoo.com - March 25 at 10:54 AM
Sensei Biotherapeutics Announces Inclusion in Russell 2000 IndexSensei Biotherapeutics Announces Inclusion in Russell 2000 Index
finance.yahoo.com - March 22 at 8:42 AM
Sensei Biotherapeutics to Present at Oppenheimer 31st Annual Virtual Healthcare ConferenceSensei Biotherapeutics to Present at Oppenheimer 31st Annual Virtual Healthcare Conference
finance.yahoo.com - March 9 at 8:57 AM
Sensei Biotherapeutics Announces Closing of Initial Public OfferingSensei Biotherapeutics Announces Closing of Initial Public Offering
finance.yahoo.com - February 10 at 7:28 PM
Sensei Biotherapeutics IncSensei Biotherapeutics Inc
reuters.com - February 10 at 2:27 PM
Immunotherapy company, with Boston research hub, executes $133M IPOImmunotherapy company, with Boston research hub, executes $133M IPO
bizjournals.com - February 9 at 2:13 PM
Cambrian Biopharma announces $60M in financing to develop a pipeline of companies and therapeutics to treat diseases of aging, coupled with a unique operational strategyCambrian Biopharma announces $60M in financing to develop a pipeline of companies and therapeutics to treat diseases of aging, coupled with a unique operational strategy
finance.yahoo.com - February 9 at 2:13 PM
Sensei Biotherapeutics Inc Registered Shs Stock , SNSESensei Biotherapeutics Inc Registered Shs Stock , SNSE
markets.businessinsider.com - February 6 at 5:46 PM
Sensei Biotherapeutics, Inc. (SNSE)Sensei Biotherapeutics, Inc. (SNSE)
in.finance.yahoo.com - February 5 at 4:35 PM
Cancer biotech Sensei Biotherapeutics prices upsized IPO above the range at $19Cancer biotech Sensei Biotherapeutics prices upsized IPO above the range at $19
nasdaq.com - February 5 at 4:35 PM
DateCompanyBrokerageAction
3/31/2021Angion BiomedicaOppenheimerReiterated Rating
3/8/2021Angion BiomedicaHC WainwrightInitiated Coverage
3/8/2021Angion BiomedicaStifel NicolausInitiated Coverage
3/8/2021Angion BiomedicaCowenInitiated Coverage
2/26/2021TheratechnologiesLeede Jones GabDowngrade
1/20/2021TheratechnologiesNational Bank FinancialReiterated Rating
2/26/2020TheratechnologiesEchelon Wealth PartnersReiterated Rating
10/9/2019TheratechnologiesRoyal Bank of CanadaLower Price Target
7/12/2019TheratechnologiesMackieLower Price Target
7/6/2018TheratechnologiesCanaccord GenuityBoost Price Target
8/14/2020PfenexCantor FitzgeraldDowngrade
8/14/2020PfenexWilliam BlairDowngrade
8/12/2020PfenexTruist FinancialDowngrade
8/11/2020PfenexJMP SecuritiesDowngrade
5/12/2020PfenexSunTrust BanksLower Price Target
3/7/2019PfenexWedbushReiterated Rating
3/8/2021Terns PharmaceuticalsThe Goldman Sachs GroupInitiated Coverage
3/8/2021Terns PharmaceuticalsJPMorgan Chase & Co.Initiated Coverage
3/8/2021Sensei BiotherapeuticsPiper SandlerInitiated Coverage
3/1/2021Sensei BiotherapeuticsCitigroupInitiated Coverage
3/1/2021Sensei BiotherapeuticsBerenberg BankInitiated Coverage
(Data available from 5/5/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.